Subject: NVIDIA and Intel Sign License Agreements
Date: 11/22/2004 6:32:32 AM (GMT-7)
IP Address: 188.8.131.52
>SANTA CLARA, CA¦¡NOVEMBER 19, 2004¦¡NVIDIA Corporation (Nasdaq: NVDA) and Intel Corporation today announced that the companies have signed a broad, multi-year patent cross-license agreement spanning multiple product lines and product generations. Additionally, the companies signed a multi-year chipset agreement for NVIDIA to license Intel¡¯s front-side bus technology. This will enable NVIDIA to deliver the NVIDIA nForce¢â platform technology on Intel-based systems.
¡°Today¡¯s agreements are significant for both companies and, more importantly, represent a win for our mutual customers who now have more choices for enhancing the PC experience,¡± said Louis Burns, Intel vice president and general manager, Desktop Products Group.
¡°NVIDIA and Intel are working together to enhance the end-user computing experience,¡± added Jen-Hsun Huang, president and chief executive officer of NVIDIA. ¡°NVIDIA¡¯s product portfolio offers exciting technology options to Intel customers, including the NVIDIA nForce platform and the PCI Express-based SLI graphics technology solution.¡±
Intel, the world¡¯s largest chip maker, is also a leading manufacturer of computer, networking, and communications products. Additional information about Intel is available at www.intel.com/pressroom.
NVIDIA Corporation is a worldwide leader in graphics and digital media processors. The Company's products enhance the end-user experience on consumer and professional computing devices. NVIDIA graphics processing units (GPUs), media and communications processors (MCPs), and wireless media processors (WMPs) have broad market reach and are incorporated into a variety of platforms, including consumer and enterprise PCs, notebooks, workstations, PDAs, mobile phones, and video game consoles. NVIDIA is headquartered in Santa Clara, California and employs more than 2,000 people worldwide. For more information, visit the Company¡¯s Web site at www.nvidia.com.